Clinical Trials

Pancreatic Neoplasms

NCT06353646 2026-02-13

XH001 Combination With Immunocheckpoint Inhibitor and Chemotherapy for Patients With Resected Pancreatic Cancer

28 enrolled

Phase NA Not yet recruiting

Pancreatic Neoplasms

NCT07325214 2026-01-12

Chemotherapy With or Without IMD10 (Focused Ultrasound) in the Treatment of Borderline Resectable or Locally Advanced Pancreatic Cancer

136 enrolled

Phase 3 Not yet recruiting

Pancreatic Neoplasms

NCT07262567 2025-12-03

Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer

320 enrolled

Pancreatic Neoplasms

NCT05723107 2025-11-28

EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC)

Phase 1 Recruiting

15 enrolled

Pancreatic Neoplasms

NCT03704662 2025-10-08

Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma

102 enrolled

Phase 1/2 Active not recruiting

Pancreatic Neoplasms

NCT04888312 2025-10-08

OPTIMIZE-1

94 enrolled

Pancreatic Neoplasms

NCT06758544 2025-08-17

A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic Cancer

Phase 1/2 Recruiting

18 enrolled

Phase NA Not yet recruiting

Pancreatic Neoplasms

NCT07114666 2025-08-11

XH001 (New Antigen Tumor Vaccine) Combined With Chemotherapy as Adjuvant Therapy in Pancreatic Cancer

12 enrolled

Pancreatic Neoplasms

NCT06691425 2025-08-08

TORPEDO

160 enrolled

Pancreatic Neoplasms

NCT06307080 2025-07-09

Clinical Study of Multimodal Ablation Remodeling Immunosensitized PD-1 in the Treatment of Pancreatic Cancer With Liver Metastasis

12 enrolled

Phase 1 Active not recruiting

Pancreatic Neoplasms

NCT05704985 2025-05-29

Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

39 enrolled

DermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Kidney Neoplasms, Neoplasms, Pancreatic Neoplasms, Skin Neoplasms, Colorectal Neoplasms

NCT06962267 2025-05-08

A Clinical Study on the First-line Treatment of Metastatic Pancreatic Cancer With TQB2916 Injection Combined With Gemcitabine Hydrochloride for Injection and Paclitaxel for Injection (Albumin-bound Type)

Phase 2 Recruiting

50 enrolled

Pancreatic Neoplasms

NCT06840067 2025-03-25

Clinical Study of Carbon Ion Radiotherapy for Pancreatic Cancer.

62 enrolled

Phase 1/2 Not yet recruiting

Pancreatic Neoplasms

NCT06866977 2025-03-10

A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Advanced Pancreatic Cancer

10 enrolled

Pancreatic Neoplasms

NCT06344156 2025-02-28

Neoantigen Vaccine Plus Anti-PD1 and Chemotherapy as an Adjuvant Therapy for Pancreatic Cancer

Phase 1 Recruiting

43 enrolled

Pancreatic Neoplasms

NCT02671890 2025-01-07

Disulfiram and Chemotherapy in Treating Patients With Refractory Solid Tumors or Metastatic Pancreatic Cancer

Phase 1 Terminated

16 enrolled

Pancreatic Neoplasms

NCT05462496 2024-10-15

Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer

Phase 2 Recruiting

25 enrolled

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Pancreatic Neoplasms

NCT03755739 2024-06-25

Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors

Phase 2/3 Recruiting

200 enrolled

Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Kidney Neoplasms, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms

NCT06359275 2024-06-25

PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients

Phase 2 Recruiting

81 enrolled

Pancreatic Neoplasms

NCT01827553 2024-04-11

CONKO-007

Phase 3 Completed

830 enrolled

Phase 1 Not yet recruiting

Pancreatic Neoplasms

NCT06346808 2024-04-04

Oncolytic Virus Plus Anti-PD1 and Chemotherapy as Preoperative Therapy for Patients With BRPC/LAPC

20 enrolled

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidThoracic

Pancreatic Neoplasms

NCT03329950 2024-03-28

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

Phase 1 Completed

132 enrolled

Bile Duct Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Esophageal Neoplasms, Fallopian Tube Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Laryngeal Neoplasms, Liver Neoplasms, Lung Neoplasms, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Melanoma, Mouth Neoplasms, Oropharyngeal Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Lymphoma, Large B-Cell, Diffuse, Cholangiocarcinoma, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Hyper-IgM Immunodeficiency Syndrome

NCT06326736 2024-03-22

Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer

Phase EARLY_PHASE1 Recruiting

12 enrolled

Pancreatic Neoplasms

NCT04431258 2024-03-18

PanC-ASAP

Phase 1/2 Completed

150 enrolled

Pancreatic Neoplasms

NCT00089024 2023-09-29

Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer

29 enrolled 8 charts

Pancreatic Neoplasms

NCT01470417 2023-08-22

GAIN-1

10 enrolled 10 charts

Pancreatic Neoplasms

NCT03977272 2023-01-27

Combination of Anti-PD-1 Antibody and Chemotherapy in Metastatic Pancreatic Cancer

110 enrolled

Pancreatic Neoplasms

NCT04420130 2022-10-04

A Trial of Camrelizumab Combined With Ablation and Chemotherapy in Patients With Pancreatic Cancer Liver Metastasis（SHR-1210-HLJ-009）

Phase NA Withdrawn

Pancreatic Neoplasms

NCT03158779 2022-09-15

Evaluation of SBRT for Patients With Locally Advanced Unresectable Pancreatic Cancer

45 enrolled

Pancreatic Neoplasms

NCT03199144 2022-06-23

CKPancreas

Phase 2 Withdrawn

Pancreatic Neoplasms

NCT05399394 2022-06-01

FOLRT

Phase 2 Unknown

50 enrolled

Pancreatic Neoplasms

NCT02282722 2021-10-14

Improving Informed Consent for Palliative Chemotherapy

Phase NA Completed

216 enrolled 20 charts

Communication, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT01676259 2021-07-02

PROTACT

Phase 2 Unknown

80 enrolled

Neoplasms, Pancreatic Neoplasms

NCT02581501 2019-04-18

Prospective Phase I Study of GAX for Metastatic Pancreatic Cancer

Phase 1 Withdrawn

Neoplasm Metastasis, Pancreatic Neoplasms

NCT03460925 2018-05-30

IRENE

Phase NA Unknown

14 enrolled

Pancreatic Neoplasms

NCT03401827 2018-02-12

The Effect of Gemcitabine Plus Nab-paclitaxel as Secondary Chemotherapy in Advanced Pancreatic Cancer

Phase 4 Unknown

40 enrolled

Pancreatic Neoplasms

NCT00763516 2017-09-06

PC02

Phase NA Completed

8 enrolled

Pancreatic Neoplasms

NCT00685763 2017-08-24

PC01

Phase NA Completed

13 enrolled 3 charts

Pancreatic Neoplasms

NCT02984501 2016-12-07

Study of Induction Chemotherapy Followed by Radiochemotherapy in Locally Advanced Pancreatic Cancer

41 enrolled

Pancreatic Neoplasms

NCT02754180 2016-04-28

Adjuvant Gemcitabine Versus Gemcitabine With Chemoradiation in Pancreatic Adenocarcinoma With R1 Resection and/or Positive Lymph Nodes

Phase 2 Unknown

110 enrolled

Pancreatic Neoplasms

NCT00253526 2015-04-28

Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer

Phase 2 Withdrawn

Pancreatic Neoplasms

NCT00785421 2015-01-08

PROSPECT

Phase 2/3 Completed

312 enrolled

Pancreatic Neoplasms

NCT01760694 2014-08-15

Multi-Modality Therapy for Untreated Patients With Resectable or Marginally Resectable Pancreatic Cancer

Phase NA Terminated

6 enrolled

Pancreatic Neoplasms

NCT00711191 2013-12-24

A Study On An Immunostimulant Antibody In Combination With Chemotherapy For Advanced Cancer Of The Pancreas

Phase 1 Completed

22 enrolled 12 charts

Pancreatic Neoplasms

NCT00358566 2008-05-19

GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer

Phase 3 Terminated

360 enrolled